BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2883697)

  • 21. Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice.
    Yen-Koo HC; Balazs T
    Drug Chem Toxicol; 1980; 3(2):237-47. PubMed ID: 6112126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of psychotropic drugs to isolated alpha-acid glycoprotein.
    Kornguth ML; Hutchins LG; Eichelman BS
    Biochem Pharmacol; 1981 Sep; 30(17):2435-41. PubMed ID: 21043242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL; Diamond BI
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells.
    Kristiansen JE; Andersen LP; Vestergaard BF; Hvidberg EF
    Pharmacol Toxicol; 1991 May; 68(5):399-403. PubMed ID: 1682908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
    Poling A; Cleary J; Berens K; Thompson T
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1240-5. PubMed ID: 1979814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response curves of homovanillic acid in pre-frontal cortex and caudate following antipsychotic drugs: relation to clinical potencies.
    Chang WH; Chen TY; Wu HS; Hu WH; Yeh EK
    Psychopharmacology (Berl); 1988; 95(4):459-62. PubMed ID: 2905499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood levels of neuroleptics: state of the art.
    Simpson GM; Yadalam K
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of dopaminergic agonist-induced gnawing behavior by neuroleptic drugs in mice.
    Yen-Koo HC; Davis DA; Balazs T
    Drug Chem Toxicol; 1985; 8(6):495-502. PubMed ID: 2868876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissimilar dosing with high-potency and low-potency neuroleptics.
    Baldessarini RJ; Katz B; Cotton P
    Am J Psychiatry; 1984 Jun; 141(6):748-52. PubMed ID: 6145357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Neurosci Lett; 1990 May; 113(2):217-21. PubMed ID: 1974041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of blood sampling methods on dopamine-receptor-blocking activities as determined by a radioreceptor assay.
    Lai AA; Fleck RJ; Patzke JV; Glueck BG; Shaskan EG; Rosenberg BJ
    Ther Drug Monit; 1982; 4(1):89-93. PubMed ID: 6122295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia.
    Fukuoka T; Nakano M; Kohda A; Okuno Y; Matsuo M
    Pharmacol Biochem Behav; 1997 Dec; 58(4):947-53. PubMed ID: 9408199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [TRIAL SYSTEMATIZATION OF NEUROLEPTIC COMBINATIONS].
    LAMBERT PA
    Encephale; 1964; 53():SUPPL:262-75. PubMed ID: 14161540
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin.
    Hait WN; Gesmonde JF; Lazo JS
    Anticancer Res; 1994; 14(5A):1711-21. PubMed ID: 7531409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors.
    Gil-Ad I; Shtaif B; Levkovitz Y; Dayag M; Zeldich E; Weizman A
    J Mol Neurosci; 2004; 22(3):189-98. PubMed ID: 14997012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
    VOLMAT R; BEAUDOUIN JL; COLLIN J; NICOLAS-CHARLES PJ; ALLERS G
    Encephale; 1964; 53():SUPPL:250-61. PubMed ID: 14161539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.